Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02817490
Other study ID # D21775
Secondary ID
Status Completed
Phase N/A
First received June 24, 2016
Last updated June 28, 2016
Start date April 2013
Est. completion date October 2015

Study information

Verified date June 2016
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertésFrance: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
Study type Observational

Clinical Trial Summary

The Ehlers-Danlos Syndrome (SED) comprises a group of clinically and genetically heterogeneous, inherited connective tissue diseases. The hypermobility type is the most frequent. It is characterized by a generalized joint hypermobility and a hyperextension skin.

Chronic pain syndrome is often present. Its psychological impact can be significant (anxiety, depression, impact on the quality of life of the patients). The disease also requires changes and a permanent adaptability (coping). It can lead to feelings of isolation and misunderstanding.

The French association of the Ehlers-Danlos Syndromes and the rehabilitation center of the 'Croix-Rouge Française des Massues' propose a patient education program for the patients with a hypermobility type SED (the PrEduSED program). This education program is open to patients and their caregivers located in France.

The research hypothesis is that the PrEduSED program improves their coping and reduces patient anxiety at 6 months (these are the two clinical criteria on which the PrEduSED could have the most impact, given the results of the first sessions).


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients

- adults (>18 years)

- hypermobility type Ehlers-Danlos Syndrome

- participating to one education session during the study period

Caregivers

- adults (>18 years)

- caregivers of patients with hypermobility type Ehlers-Danlos Syndrome

- participating to one education session during the study period

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
patient education program
The PREDUSED patient education program aims to make the patient actor of his pathology by providing him a "box of therapeutic tools" in order to: improve his knowledge of the disease, improve the management of pain, fatigue and episodes of instability; learn to communicate about the disease; set realistic goals. The program includes theoretical information, practical cases, and discussions between participants and professionals. It is the first patient education program in France for the patients with hypermobility type Ehlers-Danlos Syndrome. It is proposed two times a year. Six patients can participate at each session.

Locations

Country Name City State
France Pôle Information Médicale Evaluation Recherche - Hospices Civils de Lyon Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in scores obtained on the Coping Strategies Questionnaire-French version (CSQ-F) The Coping Strategies Questionnaire-French version - CSQ-F measured the pain coping strategies through 21 items.
It evaluates the behavioral level of the Kirkpatrick model, the degree to which participants apply what they learned during training (level 3)
Just before the education program (day 0) and 6 months after the education program (month 6) No
Secondary Changes in Hospital Anxiety And Depression Scale (HAD) It contains 14 items. It evaluates the result level of the Kirkpatrick model, the degree to which targeted outcomes occur as a result of the training (level 4) administered just before (day 0) and 6 months after the education program (month 6) No
Secondary Changes in a satisfaction questionnaire It evaluates the reaction level of the Kirkpatrick model, the degree to which participants find the training favorable, engaging and relevant (level 1) administered just after the education program (day 4) No
Secondary Changes in a quiz It evaluates the learning level of the Kirkpatrick model, the degree to which participants acquire the intended knowledge, skills, attitude (level 2) administered just before (day 0), after the education program (day 4) and 6 months after No
Secondary Changes in a Goal Attainment Scaling (GAS) It evaluates the learning level of the Kirkpatrick model, the degree to which participants acquire the intended knowledge, skills, attitude (level 2) administered just before (day 0), after the education program (day 4) No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03359135 - Compression Garments on Hypermobility Type of Ehlers-Danlos Syndrome (CGhEDS) N/A